Dr. Marcela V. Maus is the Director of Cellular Immunotherapy at the MGH Cancer Center and a Member of the Faculty at Harvard Medical School. Dr. Maus has performed extensive investigations in the biology of T cell receptors, including the design and manufacture of chimeric antigen receptors – so called CARs – a technology that has already revolutionized the treatment of certain blood cancers.